These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange. Mahoney CD Hosp Formul; 1992 Oct; 27 Suppl 2():2-3. PubMed ID: 10122035 [TBL] [Abstract][Full Text] [Related]
10. Legal issues associated with formulary product-selection when there are two or more recognized drug therapies. Liang FZ; Greenberg RB; Hogan GF Am J Hosp Pharm; 1988 Nov; 45(11):2372-5. PubMed ID: 3228094 [TBL] [Abstract][Full Text] [Related]
11. Legal and medical issues in therapeutic interchange: implications for pharmacists, physicians, and P & T committees. Plumeri PA; Crane VS Hosp Formul; 1992 Oct; 27(10):1040-2, 1047-8. PubMed ID: 10121419 [TBL] [Abstract][Full Text] [Related]
12. Effective decision-making in a changing healthcare environment: a P & T Committee interview. Zoloth A; Yon JL; Woolf R Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815 [TBL] [Abstract][Full Text] [Related]
13. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital. Benner EJ; Mykita L; Brown K Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233 [TBL] [Abstract][Full Text] [Related]
14. Pharmaco-legal considerations in the clinical use of decongestants. Brushwood DB Pharmacotherapy; 1993; 13(6 Pt 2):135S-142S; discussion 143S-146S. PubMed ID: 7507591 [TBL] [Abstract][Full Text] [Related]
15. Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1. Mahoney C; Cichon M; Cromer M; DeGiulio H; Renshaw B; Rodriguez FA; Wert D Hosp Formul; 1992 Oct; 27 Suppl 2():4-8. PubMed ID: 10122036 [No Abstract] [Full Text] [Related]
16. Issues in formulary management: therapeutic interchange. Communicating a policy: roundtable discussion, Part 2. Cichon M; Mahoney C; Renshaw B; Cromer M; Rodriguez FA; DeGiulio H; Wert D Hosp Formul; 1992 Oct; 27 Suppl 2():9-12. PubMed ID: 10122037 [No Abstract] [Full Text] [Related]
17. Implementing an automatic fluoroquinolone therapeutic interchange program in a community hospital. Mioduch HJ Hosp Formul; 1992 Sep; 27(9):943-4, 947. PubMed ID: 10128743 [TBL] [Abstract][Full Text] [Related]
18. The effects of differences in state drug product selection laws on pharmacists' substitution behavior. Carroll NV; Fincham JE; Cox FM Med Care; 1987 Nov; 25(11):1069-77. PubMed ID: 3695637 [TBL] [Abstract][Full Text] [Related]
19. Formularies: the role of pharmacy-and-therapeutics (P&T) committees. Summers KH; Szeinbach SL Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049 [TBL] [Abstract][Full Text] [Related]
20. Challenges of a P & T Committee in a community teaching hospital. Cooke DH; Kessler J Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]